|
Figure 112 Diagnostic approach for swollen joints.
WBC, White blood cell count.
From Goldman L, Schafer AL [eds]: Cecil textbook of medicine, ed 24, Philadelphia, 2012, Saunders.
Table 64 Clinical and Radiologic Findings in Joint Disease
Condition | Site of Involvement | Discriminatory Findings |
---|---|---|
Primary osteoarthritis (F>M •>45 yr) | Hands | PIP and DIP joint involvement (Heberden and Bouchard nodes) |
Large joints (e.g., hip, knee) | Joint space narrowing | |
Spine | Degenerative disc disease | |
Erosive osteoarthritis (affects middle-aged females) | Hands | PIP and DIP joint involvement |
Rheumatoid arthritis (F>M • Rh factor positive) | Hand and wrist | Symmetric arthritis |
Large joints | Joint space narrowing | |
Spine | Atlantoaxial subluxation | |
Juvenile idiopathic arthritis (M = F • affects children) | Hands | Joint ankylosis |
Large joints (e.g., knee) | Abnormalities of growth and maturation | |
Cervical spine | Apophyseal joint fusion | |
Psoriatic arthritis (M>F •nail changes • HLA-B27 +ve) | Upper extremities (e.g., hands) | Sausage digit |
SI joints | Asymmetric or unilateral sacroiliitis | |
Spine | Coarse syndesmophytes | |
Reites syndrome (affects young male adults) | Lower extremities (e.g., foot) | Hallux involvement |
Spine | Coarse syndesmophytes | |
SI joints | Asymmetric or unilateral sacroiliitis | |
Ankylosing spondylitis (M>F • affects young adults • HLA-B27 +ve in 95%) | SI joints | Bilateral symmetric sacroiliitis |
Spine | Anterior vertebral body squaring | |
Pelvis | Whiskering of the iliac crests and ischial tuberosities | |
Enteropathic arthropathies | SI joints | Symmetric sacroiliitis |
Gout (M>F) | Hands and feet (especially the great toe) | MTP joint of the great toe |
CPPD crystal deposition disease (M = F) | Any peripheral joint | Degenerative changes |
HA crystal deposition disease (M = F) | Predilection for the shoulder (supraspinatus tendon) | Periarticular calcification |
Hemochromatosis (M>F) | Hands | 2nd and 3rd MCP joint involvement (squared metacarpal heads) |
Alkaptonuria (ochronosis) (M = F) | Intervertebral discs | Degenerative changes: Disc calcification |
Systemic lupus erythematosus (F>M • affects young adults) | Hands | Reversible MCP joint subluxation |
Scleroderma (F>M • affects adults) | Hands | IP joint arthritis |
Mixed connective tissue disease (overlap syndrome) | Hands | PIP joint, MCP joint, mid-carpal involvement |
Multicentric reticulohistiocytosis (F>M) | Hands and feet | DIP joint and carpal involvement |
Polymyositis/dermatomyositis | Proximal extremities | Soft tissue calcification |
Hands | DIP joint erosions | |
Sarcoidosis | Distal and middle phalanges of the hands and feet | Punched-out cystlike lesions |
Hemophilic arthropathy (affecting males-but with female carriers) | Predilection for large joints (e.g., knee) | Epiphyseal overgrowth |
Neuropathic arthropathy | Any joint | 5 Ds: Normal bone Density |
Hypertrophic osteoarthropathy | Tubular bones (radius and ulna >tibia and fibula) | Diaphyseal and metaphyseal painful periostitis |
CPPD, Calcium pyrophosphate deposition disease; DIP, distal interphalangeal; F, female; HA, hydroxyapatite; HLA, human leukocyte antigen; IP, interphalangeal; M, male; MCP, metacarpophalangeal; MTP, metatarsophalangeal; PIP, proximal interphalangeal; Rh, Rhesus; SI, sacroiliac.
From Grant LA, Griffin N: Grainger & Allisons diagnostic radiology essentials, ed 2, Philadelphia, 2019, Elsevier.
Table 65 Contraindications to Arthrocentesis and Joint Injection
Contraindication | Comment | ||
---|---|---|---|
Established infection in nearby structures (e.g., cellulitis, septic bursitis) | Sometimes gout mimics cellulitis, creating a confusing picture | ||
Septicemia (theoretic risk of introducing organism into joint) | Need to tap suspected septic joints in septic patients | ||
Disrupted skin barrier (e.g., psoriasis) | Do not tap through lesions | ||
Bleeding disorder (not absolute, but use more care) | Risk of bleeding very low, even in patients taking warfarin | ||
Septic joint | Steroid injection contraindicated | ||
Prior lack of response | Relative contraindication | ||
Difficult-to-access joint | Relative contraindication without imaging aid |
From Firestein GS et al: Kelleys textbook of rheumatology, ed 9, Philadelphia, 2013, Saunders.
Table 66 Synovial Fluid Characteristics in Clinical Situations, with Imaging and Investigation Techniques to Identify the Cause
Diagnosis | Cells | Microorganisms | Appearance | Imaging Modality | Comments |
---|---|---|---|---|---|
Bacterial arthritis | Neutrophils, 10,000->100,000 | Gram stain usually positive | Turbid/pus | May need ultrasound to aspirate dryness | Systemic symptoms, Gram stain, blood and synovial fluid culture |
Gonococcal arthritis | Neutrophils, 10,000-100,000 | Gram stain usually positive | Turbid/pus | May need ultrasound to aspirate dryness | Systemic symptoms, Gram stain, blood and synovial fluid culture |
Crystal arthritis | Neutrophils, 10,000->100,000 | - | Turbid/pus | Radiographs, CPPD | Presence of appropriate crystals Acute serum urate unreliable |
Tuberculous arthritis | Mononuclear 5000-50,000 | Acid-fast stain often negative, may need to culture synovial tissue | Turbid/pus | At-risk population; Ziehl-Neelsen stain biopsy may be necessary | |
Inflammatory monoarthropathies | Neutrophils 5000-50,000 | - | Slightly turbid | Ultrasound/MRI for early synovitis and erosions | Serum autoantibodies such as RF, ACPA, ANA |
Osteoarthritis | Mononuclear 0-2000 | - | Clear | Radiographic changes | Usually noninflammatory CPPD may be present |
Internal derangement | Red blood cells | - | Clear/turbid | MRI | Arthroscopy may be necessary |
Trauma | Red blood cells | - | Clear/turbid | Radiographs | Tc bone scan may aid diagnosis if radiograph normal |
Ischemic necrosis | - | MRI in early disease | XR abnormal only in advanced cases | ||
Uncommon Causes | |||||
Sarcoidosis | Mononuclear, 5000-20,000 | - | CXR | ||
PVNS | Red blood cells | - | Turbid | Ultrasound and MRI | Synovial biopsy essential |
Charcot disease | Mononuclear, 0-2000 | - | Radiographs | CPPD may be present | |
Lyme disease | Neutrophils, 0-5000 | - | Clear/turbid | SF eosinophilia may be found Serology for Borrelia | |
Amyloid | Mononuclear, 2000-10,000 | - | Turbid | Synovial biopsy for Congo red stain |
ACPA, Anticitrullinated protein antibody; ANA, antinuclear antibody; CPPD, calcium pyrophosphate dehydrate deposition; CXR, chest radiograph; PVNS, pigmented villonodular synovitis; RF, rheumatoid factor; SF, synovial fluid; Tc, technetium; XR, radiograph.
From Firestein GS et al: Firestein & Kelleys textbook of rheumatology, ed 11, Philadelphia, 2021, Elsevier.
Table 67 The Differential Diagnosis of Polyarthritis
Disease Category | Specific Disease | Mono-, Oligo-, or Polyarthritis (Most Common Presentation) |
---|---|---|
Infections | ||
Viral | Parvovirus B19 | Poly |
Rubella virus | Poly | |
Hepatitis A, B, C | Poly | |
HIV | Oligo, poly | |
Alphaviruses, including Chikungunya infection | Poly | |
Bacterial | Gram-positive and gram-negative infections | Mono, occasionally oligo/poly |
Initial phase of gonorrhea | Poly | |
Later phase of gonorrhea | Mono | |
Early phase of Lyme arthritis | Poly | |
Later phase of Lyme arthritis | Oligo, mono | |
Diseases Triggered by Infection but Presumed to Be Autoimmune | ||
Reactive arthritis | After urogenital infections (Chlamydia and Ureaplasma); after gastrointestinal infections (Yersinia, Shigella, Campylobacter, and Salmonella) | Mono, oligo, poly |
Acute rheumatic fever | After infection with group A streptococcus | Oligo |
Autoimmune Diseases | ||
Primary arthritides | Rheumatoid arthritis | Poly |
Psoriatic arthritis | Oligo, poly | |
Spondyloarthropathies | Oligo, poly | |
Juvenile inflammatory arthritis | Mono, oligo, poly | |
Transient and recurring polyarthritides | Palindromic rheumatism | Poly |
Recurrent symmetric seronegative synovitis with pitting edema (RS3PE syndrome) | Poly | |
Systemic autoimmune disease | Systemic lupus erythematosus | Poly |
Mixed connective tissue disease | Poly | |
Primary Sjögren syndrome | Poly | |
Progressive systemic sclerosis and limited scleroderma | Poly | |
Behçet disease | Oligo, poly | |
Sarcoidosis | Oligo, poly | |
Vasculitis | Poly | |
Autoinflammatory diseases | Adult-onset Still disease | Oligo, poly |
Familial Mediterranean fever and other cryopyrin-associated fever syndromes | Poly | |
Various genetic autoinflammatory conditions usually manifested first in childhood | Poly | |
Degenerative diseases | Includes erosive inflammatory osteoarthritis | Poly |
Osteoarthritis | ||
Hypertrophic osteoarthropathy | Poly | |
Osteonecrosis | Mono, oligo | |
Metabolic Diseases | ||
Thyroid diseases | Hypothyroidism | Mono, oligo |
Hemochromatosis | Hyperthyroidism (Graves disease; early phase of Hashimoto disease) | Oligo, poly |
Hemoglobinopathies | Sickle cell anemia | Oligo, poly |
Hemochromatosis | Thalassemia | Oligo, poly |
Crystal diseases | Gout | Mono (initial), oligo, poly (late stage) |
Pseudogout | Mono, oligo, poly | |
Deposition diseases | Glycogen storage diseases; amyloid deposition in primary amyloidosis; mucopolysaccharidoses; light- and heavy-chain deposition diseases; others | Oligo, poly |
Drug-Induced Diseases | ||
Vasculitic drug reactions, serum sickness | Poly |
From Firestein GS et al: Firestein & Kelleys textbook of rheumatology, ed 11, Philadelphia, 2021, Elsevier.